000282331 001__ 282331
000282331 005__ 20251120152542.0
000282331 0247_ $$2doi$$a10.1007/s00702-025-02982-4
000282331 0247_ $$2pmid$$apmid:40986033
000282331 0247_ $$2ISSN$$a0375-9245
000282331 0247_ $$2ISSN$$a0022-3026
000282331 0247_ $$2ISSN$$a0300-9564
000282331 0247_ $$2ISSN$$a1435-1463
000282331 037__ $$aDZNE-2025-01292
000282331 041__ $$aEnglish
000282331 082__ $$a610
000282331 1001_ $$aPoplawska-Domaszewicz, Karolina$$b0
000282331 245__ $$aManagement of neuropsychiatric, motor and non-motor symptoms in Parkinson´s disease after long distance air travel: a consensus view.
000282331 260__ $$aWien [u.a.]$$bSpringer$$c2025
000282331 3367_ $$2DRIVER$$aarticle
000282331 3367_ $$2DataCite$$aOutput Types/Journal article
000282331 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1763648586_2193$$xReview Article
000282331 3367_ $$2BibTeX$$aARTICLE
000282331 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000282331 3367_ $$00$$2EndNote$$aJournal Article
000282331 520__ $$aHigh altitude airline travel can have various effects on health in normal subjects. The effect of airline long distance travelling at high altitude on Parkinson's disease is not clearly known, and occasional reports suggest that after long-haul flights parkinsonian motor and aspects of nonmotor states may worsen temporarily. Worsening of parkinsonian state may be linked to air travel related dehydration, hypoxic effect of decreased oxyhaemoglobin saturation, jet lag, alteration in timing of drug intake as well as potential effect on sleep wake cycle and autonomic dysfunction causing syncope. Although symptoms are generally reversible, appropriate pre-travel planning, personalized to Parkinson's disease subtype and disease, is essential to mitigate risks. Here, we provide an evidence-based overview of challenges and management strategies for Parkinson's disease patients undertaking long-distance air travel.
000282331 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000282331 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000282331 650_7 $$2Other$$aAirline travel
000282331 650_7 $$2Other$$aDehydration
000282331 650_7 $$2Other$$aHypoxia
000282331 650_7 $$2Other$$aNonmotor
000282331 650_7 $$2Other$$aParkinson’s disease
000282331 650_7 $$2Other$$aSyncope
000282331 650_2 $$2MeSH$$aHumans
000282331 650_2 $$2MeSH$$aParkinson Disease: therapy
000282331 650_2 $$2MeSH$$aParkinson Disease: complications
000282331 650_2 $$2MeSH$$aParkinson Disease: physiopathology
000282331 650_2 $$2MeSH$$aAir Travel
000282331 650_2 $$2MeSH$$aConsensus
000282331 7001_ $$aKaasinen, Valtteri$$b1
000282331 7001_ $$avan der Plas, Anton Adriaan$$b2
000282331 7001_ $$aBarbosa, Pedro Melo$$b3
000282331 7001_ $$aHeim, Beatrice$$b4
000282331 7001_ $$aSlawek, Jaroslaw$$b5
000282331 7001_ $$aFalup-Pecurariu, Cristian$$b6
000282331 7001_ $$aPirtosek, Zvezdan$$b7
000282331 7001_ $$0P:(DE-2719)9000306$$aStorch, Alexander$$b8$$udzne
000282331 7001_ $$aChen, Rosabel$$b9
000282331 7001_ $$aSchröter, Nils$$b10
000282331 7001_ $$aJost, Wolfgang H$$b11
000282331 7001_ $$aChaudhuri, K Ray$$b12
000282331 773__ $$0PERI:(DE-600)1481655-6$$a10.1007/s00702-025-02982-4$$gVol. 132, no. 11, p. 1699 - 1703$$n11$$p1699 - 1703$$tJournal of neural transmission$$v132$$x0375-9245$$y2025
000282331 8564_ $$uhttps://pub.dzne.de/record/282331/files/DZNE-2025-01290_Restricted.pdf
000282331 8564_ $$uhttps://pub.dzne.de/record/282331/files/DZNE-2025-01290_Restricted.pdf?subformat=pdfa$$xpdfa
000282331 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000306$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b8$$kDZNE
000282331 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000282331 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-02$$wger
000282331 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-02$$wger
000282331 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEURAL TRANSM : 2022$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-02
000282331 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-02
000282331 9201_ $$0I:(DE-2719)5000014$$kAG Storch$$lNon-Motor Symptoms in Parkinson's disease$$x0
000282331 980__ $$ajournal
000282331 980__ $$aEDITORS
000282331 980__ $$aVDBINPRINT
000282331 980__ $$aI:(DE-2719)5000014
000282331 980__ $$aUNRESTRICTED